Pediatrix Medical
247 hedge funds and large institutions have $1.99B invested in Pediatrix Medical in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 100 reducing their positions, and 75 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
0.02% less ownership
Funds ownership: 91.37% → 91.35% (-0.02%)
9% less capital invested
Capital invested by funds: $2.18B → $1.99B (-$190M)
16% less call options, than puts
Call options by funds: $2.01M | Put options by funds: $2.39M
17% less funds holding
Funds holding: 297 → 247 (-50)
20% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 100
59% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 75
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCP
P2 Capital Partners
New York
|
+$36.3M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$34.9M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$29.6M |
| 4 |
Lazard Asset Management
New York
|
+$23.3M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$21.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
-$62.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$57.7M |
| 3 |
BHG
Blue Harbour Group
Greenwich,
Connecticut
|
-$37.6M |
| 4 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$26.4M |
| 5 |
SRF
Silver Rock Financial
Los Angeles,
California
|
-$12.5M |
MD Hedge Fund Activity: Q2 2019 in Review
247 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2019, worth a combined $1.99B — down 8.7% from $2.18B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of MD and 31 opened new positions — a net loss of 44 holders — while 100 trimmed existing stakes and 80 added.
The largest buyer was P2 Capital Partners, adding an estimated $36.3M. The largest seller was Pzena Investment Management, exiting entirely with an estimated $62.2M sold.
- 247 institutional investors held Pediatrix Medical (MD) as of Q2 2019, down from 297 in Q1 2019.
- Funds reported $1.99B of Pediatrix Medical stock for Q2 2019, down 8.7% quarter-over-quarter.
- 31 funds opened new Pediatrix Medical positions in Q2 2019 and 75 closed out, a net change of -44 holders.
- The largest Pediatrix Medical buyer in Q2 2019 was P2 Capital Partners, an estimated $36.3M added.
- The largest Pediatrix Medical seller in Q2 2019 was Pzena Investment Management, an estimated $62.2M sold.
Based on aggregated 13F filings for Q2 2019.